Genfit S.A. (OTCMKTS:GNFTF – Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totaling 61,745 shares, a growth of 64.4% from the September 30th total of 37,557 shares. Based on an average daily volume of 91 shares, the short-interest ratio is presently 678.5 days.
Genfit Price Performance
OTCMKTS GNFTF remained flat at $9.43 during trading hours on Monday. 3 shares of the company were exchanged, compared to its average volume of 600. The company’s 50 day simple moving average is $15.00 and its two-hundred day simple moving average is $11.64. Genfit has a 1-year low of $4.14 and a 1-year high of $16.50.
About Genfit
Genfit SA is a biopharmaceutical company headquartered in Lille, France, focused on developing treatments for serious diseases with significant unmet medical needs. The company’s research has historically centered on liver diseases, including metabolic dysfunction-associated steatohepatitis (MASH), and has expanded to rare and life-threatening conditions affecting the liver and other organs.
Genfit’s portfolio includes therapies and investigational programs targeting acute-on-chronic liver failure, cholestatic liver diseases, and lysosomal acid lipase deficiency.
Further Reading
- Five stocks we like better than Genfit
- 3 Tech Stocks Boosting Buyback Capacity in the Face of the Sector’s Recent Tumble
- Strategy Pauses Bitcoin Buys to Focus on Preferred Stock Buybacks
- Uranium Prices Are Near Historic Highs—So Why Hasn’t Cameco Followed?
- Royal Caribbean Buys the Beach as Norwegian Fixes the Ship
Receive News & Ratings for Genfit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genfit and related companies with MarketBeat.com's FREE daily email newsletter.
